A plenty of studies, including an insight computational analysis, have demonstrated that elevated FoxM1 expression is a major predictor of adverse outcomes across a variety of human malignancies, indicating the oncogenic activity of FoxM1 in cancer. This evidence concerns the gene FOXM1 and cancer.